Washington's largest lobby racks up another banner year on Capitol Hill

Groups tied to FDA-regulated industry paying for agency officials' trips

What the pharmaceutical industry has gotten on its political investment

Critics say FDA approval rule has meant greater use of high-cost drugs at expense of helping fewer patients